Table 1.
Patient characteristics at baseline and follow up.
| n | Baseline | Week 16 |
|---|---|---|
| 18 patients | 13 patients | |
| Gender (female) (%) | 89% | 85% |
| Age (years) | 54.5 (26–73) | 55 (29–73) |
| Disease duration | 4.5 (1–28) | 5.5 (1–28) |
| DAS28 CRP (mg/dl) | 4.52 (3.48–6.66) | 3.26 (1.97–4.76) |
| Tender joint count (0–28) | 6.5 (2–19) | 3 (0–11) |
| Swollen Joint (0–28) | 5.5 (1–13) | 1 (0–5) |
| WBMRI26 inflammation (0–52) | 8 (0–26) | 5 (1–21) |
| US28 inflammation (0–56) | 4 (0–29) | 3 (0–26) |
Values are median (range) if not otherwise indicated. N, number of patients; WBMRI26, whole body magnetic resonance imaging sum score for 26 joints; US28, ultrasound sum score for 28 joints.